Primary Record
CEFOTAXIME SODIUM
- In stock
- 4,195 g
- Purity
- 99.0 %
- CAS
- 64485-93-4
Compound Identifiers & Properties
- CAS
- 64485-93-4
- PubChem CID
- 23672566
- SMILES
- CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N/OC)/C3=CSC(=N3)N)SC1)C(=O)[O-].[Na+]
- Canonical SMILES
- CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(COC(C)=O)CS[C@H]12)c1csc(N)n1.[Na+]
Names & Synonyms
- CEFOTAXIME SODIUM
- Claforan
- Sodium cefotaxime
- Ralopar
- Tolycar
- Tolycor
- Zariviz
- Pretor
- Claforan sodium
- CEFOTAXIME SODIUM SALT
- CEFOTAXIME NA-SALT
- (+)-Cefotaxime sodium salt
- GE3J4ZL28E
- 64485-93-4
- C16H16N5NaO7S2
- CEFOTAXIME SODIUM, E-
- SPECTRUM1500165
- UNII-258J72S7TZ
- C16H17N5O7S2.Na
- Cefotaxime sodium [USAN:JAN]
- CHEMBL3561962
- SCHEMBL29761224
- HMS502G09
- AZZMGZXNTDTSME-JUZDKLSSSA-M
- HMS1920K09
- HMS2091A12
- Cefotaxime sodium [USAN:USP:JAN]
- Cefotaxime sodium salt (syn-isomer)
- EINECS 264-915-9
- CCG-38937
- EBC-12276
- EBC-28030
- HR 756
- Cefotaxime EP Impurity D Sodium Salt
- C16-H16-N5-O7-S2.Na
- ACN-038389
- CID6420026
- LP00278
- RU 24756
- TL8004572
- EN300-122614
- Cefotaxime and dextrose 2.4% in plastic container
- Cefotaxime and dextrose 3.9% in plastic container
- EN300-21687106
- CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
- Z1544404029
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-
- 65715-12-0
- CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate
- (6R-(6-a,7-b(Z)))-3-((Acetyloxy) methyl)-7-(((2-amino-4-thiazolyl) (methoxyimio) acetyl) amino)-8-oxo-5-thia-1-azabicyclo (4,2,0) oct-2-ene-2-carboxylic acid, sodium salt
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, [6R-[6alpha,7beta(E)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, sodium salt (1:1), (6R,7R)-
- Sodium (6R,7R)-3-(acetoxymethyl)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium (6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7(sup 2)-(Z)-(O-methyloxime), acetate (ester)
- Sodium [6R-[6alpha,7beta(Z)]]-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium(6R,7R)-3-(acetoxymethyl)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate